Screening Protocol for the Evaluation of Research Participants
|ClinicalTrials.gov Identifier: NCT01036217|
Recruitment Status : Completed
First Posted : December 21, 2009
Last Update Posted : July 2, 2017
- The National Institute on Drug Abuse (NIDA) uses a standardized set of procedures to develop a pool of potential participants for research studies. Because some of the data collected during screening are used later for research, the screening itself is considered a study. An applicant to any NIDA study is considered a participant in NIDA screening.
- To identify, recruit, and screen participants for NIDA research protocols.
- Individuals 18 years of age and older who are able to provide informed consent.
- Individuals who are eligible for screening will undergo two interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview.
- The in-person interview may require up to five visits to NIDA. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff.
- During screening, a photograph will be taken for confirmation of identity during subsequent visits for other studies.
- No clinical care will be provided as part of screening.
|Condition or disease|
|Substance Abuse Disorders|
|Study Type :||Observational|
|Estimated Enrollment :||55000 participants|
|Official Title:||Evaluation of Potential Research Subjects - Screening Protocol for Clinical Studies|
|Study Start Date :||May 17, 2006|
|Estimated Study Completion Date :||June 17, 2010|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01036217
|United States, Maryland|
|National Institute on Drug Abuse, Biomedical Research Center (BRC)|
|Baltimore, Maryland, United States, 21224|